Article thumbnail

Gender differences in clinical, immunological, and virological outcomes in highly active antiretroviral-treated HIV–HCV coinfected patients

By Joel Emery, Neora Pick, Edward J Mills and Curtis L Cooper
Topics: Original Research
Publisher: Dove Medical Press
OAI identifier: oai:pubmedcentral.nih.gov:2875719
Provided by: PubMed Central

To submit an update or takedown request for this paper, please submit an Update/Correction/Removal Request.

Suggested articles

Citations

  1. A review of barriers and facilitators of HIV treatment among injection drug users.
  2. (2008). Admission characteristics, diagnoses and outcomes of HIV-infected patients registered in an ambulatory HIV-care programme in western Kenya. East Afr Med J.
  3. Antiretroviral medications during pregnancy for therapy or prophylaxis.
  4. Antiretroviral Therapy Cohort Collaboration. Life expectancy of individuals on combination antiretroviral therapy in high-income countries: a collaborative analysis of 14 cohort studies.
  5. Barriers to hepatitis C virus treatment in a Canadian HIV-hepatitis C virus coinfection tertiary care clinic.
  6. Clinical progression, survival, and immune recovery during antiretroviral therapy in patients with HIV-1 and hepatitis C virus coinfection: the Swiss HIV Cohort Study.
  7. (2008). Considerations for the antiretroviral management of women in
  8. (2002). Does patient sex affect human immunodeficiency virus levels? Clin Infect Dis.
  9. Effect of treatment with efavirenz on neuropsychiatric adverse events of interferon in HIV/HCV-coinfected patients.
  10. Factors associated with spontaneous clearance of hepatitis C virus among illicit drug users.
  11. Gender and long-term metabolic toxicities from antiretroviral therapy in HIV-1 infected persons.
  12. (2004). Gender differences in HIV-1 RNA rebound attributed to incomplete antiretroviral adherence among HIV-Infected patients in a population-based cohort. J Acquir Immune Defic Syndr.
  13. Gender-based differences in treatment and outcome among HIV patients in South India.
  14. Hepatitis C virus coinfection and HIV load, CD4+ cell percentage, and clinical progression to AIDS or death among HIV-infected women: Women and Infants Transmission Study. Clin Infect Dis.
  15. HIV Epidemiology Research Study Group. Mortality, CD4 cell count decline, and depressive symptoms among HIV-seropositive women: longitudinal analysis from the HIV Epidemiology Research Study.
  16. HIV-infected inpatients in the HAART era: how do hepatitis C virus coinfected patients differ? AIDS Patient Care STDS.
  17. (2009). HIV/AIDS epidemic in Eastern Europe: recent developments in the Russian Federation and Ukraine among women. Gend Med.
  18. Initial plasma HIV-1 RNA levels and progression to AIDS in women and men.
  19. Longitudinal trends in antiretroviral use in a cohort of men and women
  20. Neuropsychiatric aspects of coinfection with HIV and hepatitis C virus.
  21. PACTG 1025 Protocol Team. Adherence to antiretrovirals among US women during and after pregnancy.
  22. (2001). Pregnancy and infection with human immunodeficiency virus. Clin Obstet Gynecol.
  23. (2000). Prevalence and predictors of highly active antiretroviral therapy use in patients with HIV infection in the United States. HCSUS Consortium. HIV Cost and Services Utilization. J Acquir Immune Defic Syndr.
  24. Progression to AIDS and death and response to HAART in men and women from a multicenter hospital-based cohort.
  25. Progression to cirrhosis in Latinos with chronic hepatitis C: differences in Puerto Ricans with and without human immunodeficiency virus coinfection and along gender.
  26. (2001). Racial and gender disparities in receipt of highly active antiretroviral therapy persist in a multistate sample of HIV patients in
  27. (1997). Reframing women’s risk: social inequalities and HIV infection. Annu Rev Public Health.
  28. (2008). Role of depression, stress, and trauma in HIV disease progression. Psychosom Med.
  29. Sex differences in HIV-1 viral load and progression to AIDS.
  30. Sex differences in the clinical, immunological and virological parameters of HIV-infected patients treated with HAART.
  31. Sex issues in HIV-1-infected persons during highly active antiretroviral therapy: a systematic review.
  32. The integration of STD/HIV services with contraceptive services for young women in the United States.
  33. The rate of treatment of chronic hepatitis C in patients co-infected with HIV in an urban medical centre.
  34. Therapeutical aspects and outcome of HIV/HCV coinfected patients treated with pegylated interferon plus ribavirin in an Italian cohort.
  35. Women’s health. The role of gender in HIV progression.